TAG:
lab tech
Rosetta Genetics, Aureon Biosciences, Plus Diagnostics, Atherotech, Sequenom
By Robert Michel | From the Volume XVIII No. 14 – October 17, 2011 Issue
ROSETTA GENOMICS TO LAY OFF 35 EMPLOYEES TO CUT EXPENSES AND SHIFT MORE FUNDING toward sales of its proprietary molecular tests, Rosetta Genomics says it will eliminate 35 jobs. The company, based in Israel, operates a clinical laboratory in Philadelphia, Pe…
Office-Based Physicians Want In-Clinic Laboratories
By Joseph Burns | From the Volume XVIII No. 6 – May 2, 2011 Issue
CEO SUMMARY: Interest by office-based physicians in creating an in-clinic medical testing laboratory is on the increase. This has direct consequences for independent commercial labs, hospital lab outreach programs, and anatomic pathology groups, since office- based physicians are…
Educated Consumers Buying 250-Bioassay Lab Test Panel
By Robert Michel | From the Volume XVI No. 9 – June 29, 2009 Issue
CEO SUMMARY: Biophysical Corporation is creating a new, direct-to-consumer market for laboratory testing. Its unique approach is to offer 250-bioassay test panels—along with a staff physician review of results—to the educated, informed consumer. Testing multiple biomarkers ma…
April 27, 2009 “Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XVI No. 6 – April 27, 2009 Issue
As unemployment rates climb in the United States, employers are ordering fewer pre-employment drugs of abuse (DOA) screening panels. This is expected. It is why investors know that drugs-of-abuse volumes are closely linked to the economic boom/bust cycle. During first quarter earning calls, public la…
Labs Should Prepare for Tighter CLIA Enforcement
By Robert Michel | From the Volume XV No. 4 – March 24, 2008 Issue
CEO SUMMARY: Lab directors and pathologists should take notice of disturbing new developments in enforcement of CLIA regulations. During the past year, CMS officials have revoked the CLIA certification of several hospital laboratories for what are, essentially, inadvertent violations of p…
Hospital Lab Takes CMS To Court in CLIA Case
By Robert Michel | From the Volume XV No. 4 – March 24, 2008 Issue
CEO SUMMARY: A California hospital challenged CMS in federal court over the threatened loss of its lab’s CLIA certificate. CMS threatened to revoke the certificate in 2007 and stop paying the hospital’s Medicare and Medi-Cal lab bills. In January, Victor Valley Community Hospital won …
ARUP, Motoman Automate Thawing and Mixing Steps
By Robert Michel | From the Volume XIV No. 16 – November 19, 2007 Issue
CEO SUMMARY: Laboratory automation continues to develop in unexpected new directions. Recently, ARUP Laboratories and Motoman, Inc., collaborated to develop an automated thawing and mixing solution that integrates with ARUP’s existing automated line and replaces manual processes. Put in…
Shiel Medical Lab Grows In Tough NYC Market
By Robert Michel | From the Volume XIV No. 14 – October 8, 2007 Issue
CEO SUMMARY: There’s a new lab player emerging in the New York metropolitan market. Shiel Medical Laboratory of Brooklyn, New York, is growing steadily and now reports $50 million in annual revenue. It is taking full advantage of the managed care contracting turmoil and adding new clien…
IVD Executive Discusses Three Developing Trends
By Robert Michel | From the Volume XIII No. 11 – August 14, 2006 Issue
CEO SUMMARY: In a refreshingly candid assessment of current technology published in IVD Technology magazine, one lab industry executive describes both the successes and the failings of analyzers, automation, and software. He offers three trends he expects will address the deficiencies of …
Pinkus DermPath Earns ISO-9000 Certification
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: After learning about quality management systems at a recent Executive War College, the lab director at Pinkus Dermatopathology recognized how such techniques could be used in his lab to improve quality, reduce errors, and create a better working environment for both pathologi…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized